table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 prophylaxis (excluding children)
protein subunit vaccine Chappell Meng Shu Shinkai Liu
Nuvaxovid (NVX-CoV2373) Novavax Novavax PREVEND-19 phase 3 US ... Novavax phase 2 South Africa ... Novavax phase 3 UK ... Keech

0 studies excluded by filtering options 1

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons